According to Rohto Pharmaceutical's latest financial reports the company's current revenue (TTM ) is โน166.18 Billion. In 2023 the company made a revenue of โน154.64 Billion an increase over the revenue in the year 2022 that were of โน144.53 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.